Episode notes

David Mack, co-founder and CEO of PMV Pharma, gives us an in-depth look at the cancer-stopping power of P53. We discuss emerging cancer therapies, small-molecule chemistry, and future drug targets. Plus, fun stories from the invention of PCR.

Keywords
businesspharmaceuticalsciencecanceroncologyinvestor